Sep 13, 2021 10:06AM
May 20, 2021 08:00AM
May 10, 2021 03:58PM
Oct 5, 2020 08:00AM
Aug 5, 2020 08:30AM
Jul 6, 2020 08:00AM
Jun 15, 2020 08:00AM Sunovion Announces Health Canada Approval of KYNMOBI™ (apomorphine hydrochloride) Soluble Film for the Treatment of Parkinson’s Disease OFF Episodes
May 21, 2020 06:13PM
May 13, 2020 08:03AM
Apr 15, 2020 05:04PM
Dec 30, 2019 08:30AM
Dec 30, 2019 07:00AM
Dec 20, 2019 08:00AM
Dec 12, 2019 08:00AM Sunovion Announces Results from Its Open-Label Extension Study of SEP-363856 in Schizophrenia
Dec 9, 2019 11:00AM
Nov 22, 2019 09:00AM
Oct 31, 2019 09:29AM
Oct 31, 2019 09:29AM
Oct 31, 2019 09:20AM
Sep 27, 2019 08:00AM
Sep 6, 2019 09:00AM Urovant Sciences Parent Company, Roivant Sciences, and Sumitomo Dainippon Pharma Enter into a Memorandum of Understanding to Create Broad Strategic Alliance
Sep 6, 2019 03:01AM
Sep 5, 2019 10:40PM
Jul 30, 2019 08:00AM
May 10, 2019 08:00AM
May 2, 2019 08:00AM
May 1, 2019 08:00AM
Jan 30, 2019 10:15PM Sunovion Receives Complete Response Letter from FDA for Apomorphine Sublingual Film (APL-130277)
Dec 13, 2018 08:00AM
Sep 19, 2018 08:00AM
Sep 19, 2018 08:00AM
Sep 12, 2018 08:00AM
Aug 31, 2018 09:30AM
Jul 25, 2018 08:00AM
Jun 27, 2018 02:30PM Sunovion Announces Health Canada Approval of Aptiom® (eslicarbazepine acetate) as Monotherapy to Treat Partial-Onset Seizures in Adults with Epilepsy
Jun 23, 2018 09:00AM
Jun 12, 2018 05:00PM
May 16, 2018 08:23AM
May 2, 2018 08:00AM
Apr 20, 2018 11:34AM
Apr 3, 2018 08:00AM
Mar 30, 2018 08:00AM Sunovion Submits New Drug Application to the FDA for Apomorphine Sublingual Film (APL-130277) for the Treatment of OFF Episodes Associated with Parkinson’s Disease
Mar 6, 2018 03:37PM
Jan 29, 2018 04:30PM
Dec 5, 2017 08:48PM
Nov 29, 2017 08:00AM
Nov 10, 2017 10:30AM
Oct 31, 2017 08:00AM
Oct 27, 2017 04:00PM Sunovion Presents Data from Phase 3 Studies of Latuda® (lurasidone HCl) in Children and Adolescents with Bipolar Depression
Oct 24, 2017 08:00AM

1,157,740 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All